0001127602-21-018362.txt : 20210528 0001127602-21-018362.hdr.sgml : 20210528 20210528193940 ACCESSION NUMBER: 0001127602-21-018362 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210526 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Whelan, Jr. Robert M. CENTRAL INDEX KEY: 0001490045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34630 FILM NUMBER: 21982370 MAIL ADDRESS: STREET 1: ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASPEN TECHNOLOGY INC /DE/ CENTRAL INDEX KEY: 0000929940 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371] IRS NUMBER: 042739697 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 20 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-221-4302 MAIL ADDRESS: STREET 1: 20 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-05-26 0000929940 ASPEN TECHNOLOGY INC /DE/ AZPN 0001490045 Whelan, Jr. Robert M. C/O ASPEN TECHNOLOGY, INC. 20 CROSBY DRIVE BEDFORD MA 01730 1 Common Stock 2021-05-26 4 M 0 6048 15.50 A 17759 D Common Stock 2021-05-26 4 M 0 1444 133.20 A 19203 D Common Stock 2021-05-26 4 M 0 1474 130.51 A 20677 D Common Stock 2021-05-26 4 S 0 370 138.92 D 11341 D Common Stock 2021-05-26 4 S 0 5089 139.49 D 6252 D Common Stock 2021-05-26 4 S 0 3255 140.46 D 2997 D Common Stock 2021-05-26 4 S 0 252 141.06 D 2745 D Common Stock Option (Right to Buy) 15.50 2021-05-26 4 M 0 6048 0 D 2021-07-31 Common Stock 6048 0 D Director Stock Option (Right to Buy) 133.20 2021-05-26 4 M 0 1444 0 D 2019-09-03 2029-09-02 Common Stock 1444 0 D Director Stock Option (Right to Buy) 130.51 2021-05-26 4 M 0 1474 0 D 2020-12-28 2030-12-27 Common Stock 1474 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.86 to $138.96; $139.01 to $ 139.99; $140.01 to $140.98; and $141.05 to $141.09 , inclusive. The reporting person undertakes to provide to Aspen Technology, Inc., any security holder of Aspen Technology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the applicable range set forth in this footnote. The option granted at the exercise price of $15.50 was fully vested on the date of grant. The option granted at the exercise price of $133.20 was fully vested on the date of grant. The option granted at the exercise price of $130.51 was fully vested on the date of grant. /s/ F.G. Hammond, attorney-in-fact for Mr. Whelan 2021-05-28